Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
IMPROVING AND TREATING AGENT FOR RAYNAUD'S SYMPTOM
Document Type and Number:
Japanese Patent JPS5920221
Kind Code:
A
Abstract:

PURPOSE: The titled improving and treating agent, containing diltiazem or an acid addition salt thereof as an active constituent, usable continuously for a long term with almost no side effect, and administrable until there is no fear for recurrence.

CONSTITUTION: An improving and treating agent containing diltiazem: d-3-acetoxy-cis-2,3-dihydro-5-[2-(dimethylamino)ethyl]-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one which is a useful medicine having enhancing action on coronary circulation or an acid addition salt thereof as an active constituent. The remedy is capable of curing Raynaud's diseases, and removing the Raynaud's symptoms for Raynaud's syndromes or collagen diseases, etc. The dose thereof is 1W8mg/ kg/day, preferably 2W7mg/kg/day.


Inventors:
MIZUNO HIROSHI
OOSHIMA TAKAO
Application Number:
JP12737382A
Publication Date:
February 01, 1984
Filing Date:
July 21, 1982
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TANABE SEIYAKU CO
International Classes:
C07D281/10; A61K31/55; A61K31/554; A61P9/08; (IPC1-7): A61K31/55; C07D281/10
Attorney, Agent or Firm:
Shoji Nakajima